Novo Nordisk partners with Anthropic
They will leverage AI to accelerate drug discovery, bringing new medicines to patients faster.
See the latest news and media coverage for Novo Nordisk. We track all announcements, press releases, and industry mentions in real time, all in one place.
Global pharmaceutical company developing treatments for chronic diseases
novonordisk.comLast updated
In short: Novo Nordisk raised its 2026 outlook and partnered with Anthropic and AWS for AI drug discovery despite facing pipeline setbacks.
They will leverage AI to accelerate drug discovery, bringing new medicines to patients faster.
The collaboration establishes a London innovation hub and designates AWS as the primary cloud provider, aiming to compress clinical trial timelines and improve operational productivity.
The District Court of The Hague ordered Ceban to stop selling the infringing product and reimburse legal costs.
Q2 adjusted sales grew 7% and adjusted operating profit grew 11% at CER, prompting the improved full-year guidance.
Portfolio managers warn of a share price fall to 200 Danish kroner due to uncertainty regarding future growth and competitive position.
A monthly GLP-1 drug has been a long-running ambition at Novo. A few months before the Ascendis deal in 2024, the Danish pharma scrapped a...
A study linked 15 cases of Wernicke encephalopathy to GLP-1 drugs like Ozempic and Mounjaro, raising...
The pharmaceutical giant re-registers its name and revises its brand identity while the share price is under pressure.
Track Novo Nordisk and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Browse news for competitors to Novo Nordisk and other trending companies.